Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-02-11 @ 10:08 PM
Study NCT ID:
NCT03359460
Status:
COMPLETED
Last Update Posted:
2021-10-19
First Post:
2017-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome
Sponsor:
Brian Jonas
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1043625
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None